G1 Therapeutics Inc (GTHX)
3.99
+0.13
(+3.37%)
USD |
NASDAQ |
Apr 26, 16:00
3.985
0.00 (0.00%)
After-Hours: 20:00
G1 Therapeutics Enterprise Value: 177.68M for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 177.68M |
| April 25, 2024 | 170.89M |
| April 24, 2024 | 177.68M |
| April 23, 2024 | 188.12M |
| April 22, 2024 | 183.42M |
| April 19, 2024 | 183.94M |
| April 18, 2024 | 187.07M |
| April 17, 2024 | 192.81M |
| April 16, 2024 | 182.37M |
| April 15, 2024 | 194.38M |
| April 12, 2024 | 206.91M |
| April 11, 2024 | 213.69M |
| April 10, 2024 | 212.13M |
| April 09, 2024 | 224.13M |
| April 08, 2024 | 218.39M |
| April 05, 2024 | 218.91M |
| April 04, 2024 | 207.43M |
| April 03, 2024 | 215.78M |
| April 02, 2024 | 209.52M |
| April 01, 2024 | 206.91M |
| March 28, 2024 | 194.90M |
| March 27, 2024 | 202.73M |
| March 26, 2024 | 193.34M |
| March 25, 2024 | 185.51M |
| March 22, 2024 | 178.20M |
| Date | Value |
|---|---|
| March 21, 2024 | 162.54M |
| March 20, 2024 | 149.49M |
| March 19, 2024 | 140.62M |
| March 18, 2024 | 136.96M |
| March 15, 2024 | 131.74M |
| March 14, 2024 | 132.26M |
| March 13, 2024 | 150.01M |
| March 12, 2024 | 142.70M |
| March 11, 2024 | 151.05M |
| March 08, 2024 | 159.41M |
| March 07, 2024 | 156.27M |
| March 06, 2024 | 153.66M |
| March 05, 2024 | 154.19M |
| March 04, 2024 | 160.45M |
| March 01, 2024 | 164.10M |
| February 29, 2024 | 142.70M |
| February 28, 2024 | 143.22M |
| February 27, 2024 | 94.68M |
| February 26, 2024 | 89.46M |
| February 23, 2024 | 84.68M |
| February 22, 2024 | 81.04M |
| February 21, 2024 | 81.56M |
| February 20, 2024 | 86.75M |
| February 16, 2024 | 92.99M |
| February 15, 2024 | 94.02M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.835M
Minimum
Sep 25 2023
1.198B
Maximum
Sep 11 2019
368.18M
Average
333.51M
Median
Enterprise Value Benchmarks
| Amicus Therapeutics Inc | 3.138B |
| Geron Corp | 1.818B |
| Palatin Technologies Inc | 19.88M |
| Oragenics Inc | 3.037M |
| TG Therapeutics Inc | 1.963B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.88M |
| Revenue (Quarterly) | 14.87M |
| Total Expenses (Quarterly) | 23.80M |
| EPS Diluted (Quarterly) | -0.21 |
| Gross Profit Margin (Quarterly) | 91.56% |
| Profit Margin (Quarterly) | -73.14% |
| Earnings Yield | -23.81% |
| Normalized Earnings Yield | -23.81 |